Clinical Trials Ontario (CTO) is seeking additional members for its Patient and Public Advisory Group (P2AG). Mar 15 2019

[A Former User]

I got this via email:

BE A MEMBER OF AN ADVISORY GROUP: Clinical Trials Ontario’s Patient and Public Advisory Group

What is the opportunity?

Clinical Trials Ontario (CTO) is seeking additional members for its Patient and Public Advisory Group (P2AG).

In 2017, CTO created the P2AG to ensure that their activities are informed and improved by the perspectives and advice of patients and the public.

They are currently seeking 3-4 new members to join the P2AG. You do not need to know about clinical trials to be involved – as long as you are interested in clinical trials and live in Ontario there may be a role for you.

Who is Clinical Trials Ontario?

Clinical Trials Ontario is an independent not-for-profit organization established with support from the Government of Ontario. Their mandate is to work with the clinical trials community, the public, and other partners to improve clinical trials in Ontario. Since 2012 they have been carrying out that mandate while keeping one of their three strategic pillars in mind; patient and public engagement. They believe engaging patients and the public is critical to improving the environment for clinical trials in Ontario and will result in better clinical trials, better experiences for trial participants, better physician-researcher experiences, and in the long run, a better health care system. More information about Clinical Trials Ontario can be found at www.ctontario.ca.

Time Commitment: A 2-year commitment, with quarterly meetings in-person (1.5 to 2 days each), and potentially the option to attend CTO’s annual conference (usually a 2-day event).

Location: In-person meetings are usually in Toronto.

Supports provided: You will be provided with an honorarium for your participation (if you wish) and have your travel, meal and accommodation expenses covered to attend any in-person meetings.

How you can help:

To be part of the P2AG, we would ask that you:

• Be prepared for and attend quarterly meetings in person

• Openly and constructively participate in discussions, provide feedback, raise issues, and work with others to solve problems;

• Participate in training about the research process and clinical trials;

• Contribute to an open environment, while working well with others and keeping your personal interests separate from the conversations.

• Support the mandate of Clinical Trials Ontario;

• Provide constructive feedback as well as criticism;

• Use your knowledge, personal and professional networks, and experience to provide input into discussions and decisions;

• Take the lead on further patient and public engagement.

TO SUBMIT AN EXPRESSION OF INTEREST:

If you are interested in this opportunity, please contact Dawn Richards (dawn.richards@ctontario.ca), CTO’s Director of Patient and Public Engagement including the following information:

• Why you are interested in being part of the P2AG;

• The contribution you could make to the P2AG (skills, experience, or perspectives);

• Any involvement you have with patient or healthcare organizations (this is not a requirement to participate);

• Where you live;

• You may share any other communities you are a part of (e.g., an ethnic or cultural community, LGBTQ, youth)

• Whether you would be interested in remaining connected to CTO even if you are not invited to participate in the P2AG (in this case, your name and email address will be placed on a mailing list). CTO would like to build a community of people who are interested in clinical trials in order share information with them about this topic, such as educational opportunities and websites, interesting research, and other potential opportunities to be involved in research with some of our partners.

Thank you in advance for your interest in participating.

For more information:

Email Dawn Richards at dawn.richards@ctontario.ca

Deadline for applications: If you are interested, we ask that you please respond by March 15th, 2019.